1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. VERTEX PHARMACEUTICALS, INC.
Vertex Pharmaceuticals, Inc. XNAS: VRTX

Vertex Pharma Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, whe...

Read More
499.17 38.30 (8.31%)
Near 52W High of $519.68
3.4M
XNAS Volume
High volume+gain today

XNAS 10 Mar, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The board meeting for Vertex Pharma is scheduled for today, for the purpose of Barclays 28th Annual Global Healthcare Conference See details
Durability score
Medium Financial Strength
38.9 / 100
Valuation Score
Mid Valuation
42.7 / 100
Momentum Score
Technically Neutral
59.7 / 100
Mid-range Performer These stocks have average quality, financial and technical momentum, indicating a mid range performer View Similar Embed DVM
Analyst Price Target
546
1Yr Price target upside is 9%
27 analysts

24

S

4

W

5

O

0

T

SWOT Analysis

Vertex Pharma Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..